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Allergen specific immunotherapy (ASIT) is the only dis-
ease modifying treatment of allergic diseases. A key ele-
ment in the protective effect is thought to be induction
of a specific IgG4 response leading to a decrease in the
IgE-mediated allergic symptoms. The effect of ASIT can
be ascertained by provocation or skin prick testing. IgE
measurement by ImmunoCAP is a sensitive standard
procedure for allergy diagnosis and this has recently been
supplemented by a single allergen array (ISAC), which
employs significantly lower amounts of allergen and may
have different assay dynamics. 24 subjects suffering from
allergic rhinitis due to grass pollen allergy were stratified
on basis of sensitivity in a basophil activation test, to
receive standard subcutaneous immunotherapy (n=18) or
to an open control group (n=6). Allergen specific IgE and
IgG4 was measured at baseline and when reaching main-
tenance dose by using both the quantitative ImmunoCAP
for Phl p1 and Phl p5 and the chip-based semi-quantita-
tive ISAC method (Phl p 1, 2, 4, 5, 6, 7, 11 and 12). Data
are presented as mean and 95% CI. ASIT treatment
reduced self-reported symptoms from 10,7 to 5,5
(p=0,0001). ASIT increased allergen specific IgG4 levels,
both by ISAC (from 0,3 to 5,0 ISAC specific units (ISU)
(Δ 4,7 ISU; 2,7-6,7 ISU; p=0,0001) and ImmunoCAP
(from 0,1 to 5,2 mg/l, Δ 5,1 mg/l; 2,3-7,9 mg/ml;
p=0,0006). Specific IgE increased from 23,0 to 48,8 kU/l
when measured by ImmunoCAP (Δ 25,8 kU/l; 4,4-47,2;
p=0,01). Surprisingly, ISAC measurement of specific IgE
decreased from 21,4 to 2,5 ISU (Δ 18,9 ISU; -10,0;-27,8;
p=0,0002) during updosing. No significant changes in
IgG4 or IgE measurements were found in the control
group during the treatment period. ImmunoCAP
measurements indicate that IgG4 and IgE increase during
ASIT updosing as previously reported. In contrast, when
IgE in the same serum samples was measured by ISAC a
decrease in IgE seems to be the result of successful ASIT.
This may be the result of inhibition of IgE-binding in vitro
in the ISAC assay, possibly reflecting functional IgE inhibi-
tion in vivo in the treated patients. ISAC measurements
before and after ASIT may thus be useful in monitoring
the clinical effect of allergen specific immunotherapy.
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